Evidence map›Paper›PMID 23846569›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2013

Randomized comparison of universal and targeted HIV screening in the emergency department.

Michael S Lyons, Christopher J Lindsell, Andrew H Ruffner, D Beth Wayne, Kimberly W Hart, Matthew I Sperling, Alexander T Trott, Carl J Fichtenbaum

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Testing Cancer Patients for HIV: Just Do It.Acta medica Philippina · 2024
    Article
  14. Observational
  15. Article
  16. Reimagining Preexposure Prophylaxis Provision for Women in the United States.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. How to best conduct universal HIV screening in emergency departments is far from settled.Journal of the American College of Emergency Physicians open · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael S Lyons*Department of Emergency Medicine; and †Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH.
Christopher J Lindsell
Andrew H Ruffner
D Beth Wayne
Kimberly W Hart
Matthew I Sperling
Alexander T Trott
Carl J Fichtenbaum

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR026314 · NCRR · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2009 to 2011
$14.3M
HIV Screening in the Emergency Department SettingK23AI068453 · NIAID · UNIVERSITY OF CINCINNATI · PI LYONS, MICHAEL S · 2006 to 2010
$668k
NCRR NIH HHS 5UL1RR026314-03NCRR NIH HHS UL1 RR026314NIAID NIH HHS K23 AI068453
6 · The paper itself

Abstract

objectiveUniversal HIV screening is recommended but challenging to implement. Selectively targeting those at risk is thought to miss cases, but previous studies are limited by narrow risk criteria, incomplete implementation, and absence of direct comparisons. We hypothesized that targeted HIV screening, when fully implemented and using maximally broad risk criteria, could detect nearly as many cases as universal screening with many fewer tests.

methodsThis single-center cluster-randomized trial compared universal and targeted patient selection for HIV screening in a lower prevalence urban emergency department. Patients were excluded for age (<18 and >64 years), known HIV infection, or previous approach for HIV testing that day. Targeted screening was offered for any risk indicator identified from charts, staff referral, or self-disclosure. Universal screening was offered regardless of risk. Baseline seroprevalence was estimated from consecutive deidentified blood samples.

resultsThere were 9572 eligible visits during which the patient was approached. For universal screening, 40.8% (1915/4692) consented with 6 being newly diagnosed [0.31%, 95% confidence interval (CI): 0.13% to 0.65%]. For targeted screening, 37% (1813/4880) had no testing indication. Of the 3067 remaining, 47.4% (1454) consented with 3 being newly diagnosed (0.22%, 95% CI: 0.06% to 0.55%). Estimated seroprevalence was 0.36% (95% CI: 0.16% to 0.70%). Targeted screening had a higher proportion consenting (47.4% vs. 40.8%, P < 0.002), but a lower proportion of ED encounters with testing (29.7% vs. 40.7%, P < 0.002).

conclusionsTargeted screening, even when fully implemented with maximally permissive selection, offered no important increase in positivity rate or decrease in tests performed. Universal screening diagnosed more cases, because more were tested, despite a modestly lower consent rate.

Indexed as

Emergency Service, HospitalAdolescentAdultCluster AnalysisEarly DiagnosisFemaleHIV InfectionsHospitals, UrbanHumansInformed ConsentMaleMass ScreeningMiddle AgedOhioPatient Acceptance of Health CarePatient Selection

Identifiers

PMID23846569
PMCPMC4241750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.